Selank 10MG

Research Profile

Selank 10mg is a synthetic research peptide also identified as TP-7. It is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and is structurally related to tuftsin-based peptide research. Selank has been studied in laboratory settings involving regulatory peptide activity, neuropeptide-related pathways, and peptide stability.

Study Context

Selank research has focused on peptide signaling, gene-expression response models, and its relationship to tuftsin-derived peptide activity. Published research has explored Selank and related peptide fragments in controlled experimental systems, including studies involving inflammatory-response gene expression and regulatory peptide pathways.

Research Interest

• Tuftsin-analog research: Studied as a synthetic peptide related to tuftsin-derived structures.
• Neuropeptide pathway models: Used in research involving regulatory peptide signaling.
• Gene-expression studies: Investigated in models looking at peptide-related transcriptomic response.
• Peptide stability: The extended heptapeptide structure is of interest in peptide design and degradation-resistance research.
• Laboratory comparison studies: Often researched alongside related peptide fragments and regulatory peptides.

Product Details

Selank 10mg is supplied as a lyophilized research material in a sterile, sealed vial for controlled laboratory research. Each vial is labeled for clear product identification and intended for use with proper laboratory documentation, handling, and storage procedures.

Bacteriostatic water is necessary for reconstitution but is not included.

Lab Use Notice

For research use only — not for human or animal consumption.